Chronic Low Back Pain Clinical Trial
Official title:
A Randomised Controlled Trial of Brief Physiotherapy Informed by Acceptance and Commitment Therapy for Chronic Low Back Pain: the PACT Study
Chronic low back pain (CLBP) is very common and causes much pain and disability. It costs the
NHS billions of pounds in treatment every year and is the second leading cause of time off
work. There are various treatments for CLBP, but the most effective are still only moderately
helpful. Most people with CLBP receive physiotherapy, with varying results. Cognitive
behaviour therapy (CBT) may offer more long term help than current treatments because it
enables people to self-manage their condition. A new type of CBT, called Acceptance and
Commitment Therapy (ACT), has produced particularly good results for chronic pain. However, a
shortage of clinical psychologists means that most patients never receive CBT.
Physiotherapists can successfully use CBT techniques with extra training, but this is not
standard practice and ACT-based physiotherapy treatment has never been tested.
The investigators have developed a short ACT-based treatment (PACT) for physiotherapists to
deliver and aim to compare it with usual physiotherapy care. The investigators will recruit
240 people with CLBP from three hospitals in South East London. They will be randomly divided
into two groups, with half receiving PACT and the other half ordinary physiotherapy. PACT
consists of two hour long sessions and one follow-up phone call, meaning fewer hospital
visits for patients and more time during sessions for individualised treatment. It aims to
encourage people to focus less on getting rid of their pain and more on moving forward with
what is most important in their lives. The investigators will compare PACT with usual
physiotherapy to see which is most successful at improving people's ability to function and
their quality of life and which approach helps them to manage their back pain best in the
long term. If PACT is effective, the investigators believe it could reduce the considerable
burden of CLBP to patients, the NHS and society.
Back pain causes considerable suffering and is a major financial burden, costing the NHS an
estimated £1.1 billion annually (Maniadakis and Gray 2000) and representing the second
largest cause of absence from work (Young and Bhaumik, 2011). Chronic low back pain (CLBP),
defined as pain lasting more than 12 weeks, is responsible for 80% of this cost (Department
of Health, 2009). Physiotherapy is a common treatment for CLBP, with 1.26 million patients
referred to NHS physiotherapists at a cost of £150 million per annum (Maniadakis and Gray,
2000). Several forms of physiotherapy are recommended for CLBP, including exercises, manual
therapy and back classes (NICE, 2009). The type of physiotherapy varies considerably in
duration and content, despite evidence that different treatments have similar effects
(Critchley et al, 2007). Most trials show no clear superiority for any treatment, with the
majority leading to only moderate improvement (Artus et al 2010).
A key focus of treatment is helping people with persistent CLBP to self-manage their
condition and thus improve pain, disability and distress to ensure that an episode of low
back pain does not result in long-term withdrawal from normal activities, including sickness
absence from paid employment. Cognitive behavioural therapy (CBT) has a good evidence base
for the treatment of chronic pain (Eccleston et al, 2009; Hoffman et al, 2007; Scascighini et
al, 2008) and the Chartered Society of Physiotherapy recognises that CBT can fall within a
physiotherapist's scope of practice (Donaghy et al 2008). However, CBT-based treatments
delivered by physiotherapist have only produced modest improvements in CLBP (Lamb et al.,
2010) and it remains unclear how to best implement cognitive and behavioural approaches
during physiotherapy interventions.
One promising theory-based approach to chronic pain is a form of CBT called Acceptance and
Commitment Therapy (ACT) (Hayes et al., 1999). The primary focus of ACT is on enhancing
psychological flexibility and reducing struggle with pain. This involves helping people to
accept their pain and related feelings, become more aware and less dominated by thoughts and
beliefs about pain, and identify and follow directions in life that reflect their values
(Vowles et al, 2011). A meta-analysis of ACT for chronic pain showed improvements in
depression, anxiety, pain intensity, physical functioning and quality of life (Veehof et al,
2011). It has good maintenance of treatment effects up to three years post treatment (Vowles
et al 2011), important in a chronic relapsing and remitting condition like CLBP. This
suggests that ACT-based interventions could be well suited to patients with CLBP. In all
published studies to date, ACT has been delivered by psychologists or within
multidisciplinary teams but there is very limited availability of clinical psychologists for
CLBP and most patients referred to secondary care are seen by physiotherapists not
psychologists (Maniadakis and Gray, 2000).
This study aims to evaluate the efficacy of a novel physiotherapy intervention incorporating
the newest and most promising form of CBT, Acceptance and Commitment Therapy (ACT) against
usual physiotherapy care. The investigators believe this will optimise outcome for patients,
the NHS and society at large. The investigators have conducted a proof of concept feasibility
study to develop a brief physiotherapist-delivered ACT-based intervention, 'PACT', consisting
of two one hour sessions plus a follow-up phone call. The aim is to test PACT against usual
physiotherapy care in a phase 2 trial. The main research question is whether PACT
(physiotherapist delivered ACT-based treatment) is effective. The investigators hypothesise
that the group receiving PACT will have improved function at 3 months compared to the
treatment as usual group, and that this will be maintained at 12 months. The primary
objective of this study is to evaluate the efficacy of PACT, a novel brief ACT-based
physiotherapy intervention for chronic low back pain, at the primary end point of function at
3 months follow-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 |